The Global Capnography Market is estimated to witness a CAGR of 19.2% during the forecast period 2018-2024.
The increase in the respiratory diseases is necessitating the development of respiratory monitoring device. The limitations of the usage of pulse oximetry to obtain the accurate status of the respiratory condition of the individual is also fueling the market. However, the presence of alternative respiratory monitoring devices such as gas analyzers and pulse oximetry are posing a threat to the market.
Based on the products, the market is segmented into devices and the disposables. The disposables market is fastest growing as each disposable lasts for an average of only two days. However, reusable disposable is being used in many hospitals and other clinics, but the risk of infection remains high. According to the Centers for Disease Control and Prevention (CDC) Annually, around 1.7 million people are getting infected by using these reusable consumables in US, out of which approximately 99,000 those lose their lives.
Based on the end-users, the market is segmented into Hospitals, ambulatory surgical centers and others. The hospitals dominate the market in 2017 due to the good reimbursement facilities and availability of skilled professionals.
The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the capnography market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by North America, with the US being the major contributor to the market growth.
Masimo Corporation, Philips Healthcare, Medtronic, Inc, Smith Medicals and Hill Rom, Inc (Welch Allyn) are the players dominating the market. These players are integrating strategies to increase their market share by product launches, expansion in the their geographical presence, merger & acquisitions and collaborative agreements.
In June 2017, Medtronic started an international study to assess the risk of on opioid induced respiratory depression (OIRD), a preventable form of respiratory condition. The company claims that this is the first study to evaluate the clinical and economic aids resulting from the use of pulse oximetry and capnography. This helps the respiratory specialists in understanding the real incidents of respiratory compromise and other unmet needs.
- Becton Dickenson
- Dia Medica Inc.
- Dragerwerk AG & Co. KGaA
- Hill Rom Inc (Welch Allyn Inc.)
- Medtronic Inc.
- Nihon Kohden Corporation
- Nonin Medical Inc.
- Philips Healthcare
- Smiths Medical
Key Topics Covered
1 Industry Outlook
2 Report Outline
3 Market Snapshot
4 Market Outlook
5 Market Characteristics
6 Product: Market Size and Analysis
7 End-users: Market Size and Analysis
8 Regions: Market Size & Analysis
9 Competitive Landscape
10 Vendors Profile
11 Companies to Watch For
For more information about this report visit https://www.researchandmarkets.com/research/dgrghk/global?w=4